Deguelin inhibits RANKL-induced osteoclastogenesis in vitro and prevents inflammation-mediated bone loss in vivo期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Deguelin inhibits RANKL-induced osteoclastogenesis in vitro and prevents inflammation-mediated bone loss in vivo

Authors:	Tan Zhang Kangxian Zhao Weiqi Han Wanlei Yang Xuanyuan Lu Qian Liu Xiucheng Li Yu Qian

Institution:	1. Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China Department of Orthopaedics, Shaoxing People's Hospital, Zhejiang University School of Medicine, Shaoxing, Zhejiang, China;2. Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China;3. Department of Orthopaedics, Shaoxing People's Hospital, Zhejiang University School of Medicine, Shaoxing, Zhejiang, China;4. Orthopaedic Department, Research Centre for Regenerative Medicine, 5. The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

Abstract:

Keywords:	deguelin nuclear factor-κB (NF-κB) osteoclast osteoclastogenesis therapeutics